INTEGRA LIFESCIENCES HOLDINGS CORP
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | |
| By: | /s/ Jan De Witte |
|---|---|
| Jan De Witte | |
| President and Chief Executive Officer, and Director | |
| (Principal Executive Officer) | |
| By: | /s/ Lea Knight |
| Lea Knight | |
| Executive Vice President and Chief Financial Officer | |
| (Principal Financial Officer) | |
| By: | /s/ Jeffrey A. Mosebrook |
| Jeffrey A. Mosebrook | |
| Senior Vice President, Finance | |
| (Principal Accounting Officer) |
Date: February 28, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons, on behalf of the registrant in the capacities indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Jan De Witte | President and Chief Executive Officer, | February 28, 2024 |
| Jan De Witte | and Director (Principal Executive Officer) | |
| /s/ Lea Knight | Executive Vice President and Chief Financial Officer | February 28, 2024 |
| Lea Knight | (Principal Financial Officer) | |
| /s/ Jeffrey A. Mosebrook | Senior Vice President, Finance | February 28, 2024 |
| Jeffrey A. Mosebrook | (Principal Accounting Officer) | |
| /s/ Stuart M. Essig, Ph.D. | Chairman of the Board | February 28, 2024 |
| Stuart M. Essig, Ph.D. | ||
| /s/ Keith Bradley, Ph.D. | Director | February 28, 2024 |
| Keith Bradley, Ph.D. | ||
| /s/ Shaundra Clay | Director | February 28, 2024 |
| Shaundra Clay | ||
| /s/ Jeffrey A. Graves | Director | February 28, 2024 |
| Jeffrey A. Graves | ||
| /s/ Barbara B. Hill | Director | February 28, 2024 |
| Barbara B. Hill | ||
| /s/ Renee W. Lo | Director | February 28, 2024 |
| Renee W. Lo | ||
| /s/ Raymond G. Murphy | Director | February 28, 2024 |
| Raymond G. Murphy | ||
| /s/ Christian S. Schade | Director | February 28, 2024 |
| Christian S. Schade | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.